Viridian TherapeuticsVRDN
那斯達克 · USD
15.77
-0.54
(-3.31%)
收盤 06/11 03:59 (UTC+8)
盤後
15.47
15.47
(-1.90%)
06/11 03:59 (UTC+8)
Viridian TherapeuticsVRDN
15.77
-0.54
(-3.31%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.71
- 0.00
- 0.00
- -
- -
- -
- 19.44
- -16.28
- -
- 4.17
- 93993.33
- -99.81
- 6.82
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 141 | 132 | 70,570 | 75 | 72 | 72 | 86 | 72 | 72 | 72 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 141 | 132 | 70,570 | 75 | 72 | 72 | 86 | 72 | 72 | 72 |
營業費用 | 116,310 | 122,881 | 110,583 | 106,842 | - | 87,544 | - | - | 55,969 | 71,550 |
研發費用 | 77,631 | 89,208 | 86,260 | 86,626 | 76,835 | 71,960 | 69,158 | 56,192 | 40,944 | 38,557 |
推銷及管理費用 | 38,679 | 33,673 | 24,323 | 20,216 | 17,103 | 15,584 | 14,408 | 16,066 | 15,025 | 32,993 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -116,169 | -122,749 | -40,013 | -106,767 | -93,866 | -87,472 | -83,480 | -72,186 | -55,897 | -71,478 |
其他收入及費用 | 14,730 | 5,676 | 5,980 | 6,582 | 7,540 | 9,113 | 7,795 | 7,790 | 7,942 | 5,534 |
利息費用 | 3,462 | 3,282 | 566 | 550 | 586 | 1,366 | 1,004 | 597 | 587 | 916 |
稅前純益 | -104,901 | -120,355 | -34,599 | -100,735 | -86,912 | -79,725 | -76,689 | -64,993 | -48,542 | -66,860 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -104,901 | -120,355 | -34,599 | -100,735 | -86,912 | -79,725 | -76,689 | -64,993 | -48,542 | -66,860 |
基本每股稅後盈餘(元) | -0.90 | -1.08 | -0.34 | -1.00 | -0.87 | -0.81 | -0.88 | -0.77 | -0.59 | -1.35 |
稀釋每股稅後盈餘(元) | -0.90 | -1.10 | -0.34 | -1.00 | -0.87 | -0.09 | -1.16 | -1.23 | -0.59 | 0.06 |
基本平均股數(千股) | 102211.00 | 94377.00 | 81784.00 | 81593.00 | 81344.00 | 80052.00 | 66420.00 | 63854.00 | 61099.00 | 49681.00 |
稀釋平均股數(千股) | 102211.00 | 94377.00 | 81784.00 | 81593.00 | 81344.00 | 80052.00 | 66420.00 | 63854.00 | 61099.00 | 49681.00 |
還原基本每股稅後盈餘(元) | -0.90 | -1.08 | -0.34 | -1.00 | -0.87 | -0.81 | -0.88 | -0.77 | -0.59 | -1.35 |
還原稀釋每股稅後盈餘(元) | -0.90 | -1.10 | -0.34 | -1.00 | -0.87 | -0.09 | -1.16 | -1.23 | -0.59 | 0.06 |
還原基本平均股數(千股) | 102,211 | 94,377 | 81,784 | 81,593 | 81,344 | 80,052 | 66,420 | 63,854 | 61,099 | 49,681 |
還原稀釋平均股數(千股) | 102,211 | 94,377 | 81,784 | 81,593 | 81,344 | 80,052 | 66,420 | 63,854 | 61,099 | 49,681 |
EBITDA(千元) | -103,175 | -118,706 | -35,056 | -101,624 | -88,529 | -81,443 | -78,932 | -68,662 | -52,473 | -68,861 |